Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · American Healthcare REIT (AHR)

American Healthcare REIT raises 2025 NFFO guidance; Q2 NOI growth 13.9%

Positive Impact 4 of 5 guidance Written later

American Healthcare REIT (NYSE: AHR) reported second quarter 2025 results on August 7, 2025, with total revenues of $542.5 million, up from $504.6 million a year earlier, and net income attributable to controlling interest of $9.9 million, or $0.06 per diluted share. The company raised its full year 2025 guidance for NFFO per diluted share and total portfolio Same-Store NOI growth, citing strong operating results in its ISHC and SHOP segments.

Key points

  • Q2 NFFO was $0.42 per diluted share, compared with $0.33 in the second quarter of 2024; GAAP net income was $0.06 per diluted share, compared with $0.01.
  • 2025 NFFO per diluted share guidance rose to $1.64 to $1.68 from $1.58 to $1.64; total portfolio Same-Store NOI growth guidance rose to 11.0% to 14.0% from 9.0% to 13.0%.
  • Net Debt-to-Annualized Adjusted EBITDA improved to 3.7x as of June 30, 2025, from 4.5x as of March 31, 2025; total liquidity was about $733.5 million.
  • The Board declared a $0.25 per share distribution for the quarter ended June 30, 2025, paid on or about July 18, 2025.

The filing

CompanyAmerican Healthcare REIT (AHR)
Form8-K, current report
Filed with the SECAug 7, 2025, 4:18 PM ET
Accession number0001632970-25-000057

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 07, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.